{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:18:20Z","timestamp":1759483100768},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1007\/s11886-001-0011-3","type":"journal-article","created":{"date-parts":[[2007,5,26]],"date-time":"2007-05-26T08:53:19Z","timestamp":1180169599000},"page":"56-62","source":"Crossref","is-referenced-by-count":5,"title":["Deep venous thrombosis prophylaxis in patients with heart disease"],"prefix":"10.1007","volume":"3","author":[{"given":"Bruce K.","family":"Shively","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"531S","DOI":"10.1378\/chest.114.5_Supplement.531S","volume":"114","author":"GP Clagett","year":"1998","unstructured":"Clagett GP, Anderson FA, Geerts W, et al.: Prevention of venous thromboembolism. Chest 1998, 114:531S-560S. This is the exhaustive summary document of guidelines from the Fifth ACCP Consensus Conference on Antithrombotic Therapy. It is the most complete single source of information about DVT prophylaxis. Unfortunately, the section on medical patients is very short and the data provided related to acute myocardial infarction is obsolete.","journal-title":"Chest"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","volume":"341","author":"MM Samama","year":"1999","unstructured":"Samama MM, Cohen AT, Darmon J-Y, et al.: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill patients. N Engl J Med 1999, 341:793\u2013800. This is the most recent trial of DVT prophylaxis in medical patients and incorporates state of the art methodology. It is also referred to as the MEDENOX study.","journal-title":"N Engl J Med"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"104B","DOI":"10.1016\/S0735-1097(86)80012-2","volume":"8","author":"J Hirsh","year":"1986","unstructured":"Hirsh J, Hull RD, Raskob GA: Epidemiology and pathogenesis of venous thrombosis. J Am Coll Cardiol 1986, 8:104B-113B.","journal-title":"J Am Coll Cardiol"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0033-0620(94)80050-2","volume":"36","author":"JS Alpert","year":"1994","unstructured":"Alpert JS, Dalen JE: Epidemiology and natural history of venous thromboembolism. Progr Cardiovasc Dis 1994, 36:417\u2013422.","journal-title":"Progr Cardiovasc Dis"},{"key":"11_CR5","first-page":"S107","volume":"13","author":"JB O\u2019Connell","year":"1994","unstructured":"O\u2019Connell JB, Bristow MJ: Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994, 13:S107-S112.","journal-title":"J Heart Lung Transplant"},{"key":"11_CR6","first-page":"1085","volume-title":"Vascular Medicine","author":"MC Donaldson","year":"1992","unstructured":"Donaldson MC: Chronic Venous Disorders. In In Vascular Medicine. Edited by Loscalzo J, Creaker MA, Dzau VJ. Boston: Little, Brown and Company, 1992: 1085\u20131098."},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.1983.03340100023022","volume":"250","author":"DE Strandness Jr.","year":"1983","unstructured":"Strandness DE Jr., Langlois Y, Cramer M: Long-term sequelae of acute venous thrombosis. J Am Med Assoc 1983, 250:1289\u20131292.","journal-title":"J Am Med Assoc"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"V49","DOI":"10.1016\/S0049-3848(99)00207-8","volume":"97","author":"G Agnelli","year":"1997","unstructured":"Agnelli G, Sonaglia F: Prevention of venous thromboembolism. Thromb Res 1997, 97:V49-V62.","journal-title":"Thromb Res"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/jama.1992.03490130115040","volume":"268","author":"SZ Goldhaber","year":"1992","unstructured":"Goldhaber SZ, Morpurgo M: Diagnosis, treatment, and prevention of pulmonary embolism. J Am Med Assoc 1992, 268:1727\u20131733.","journal-title":"J Am Med Assoc"},{"key":"11_CR10","first-page":"477","volume":"82","author":"RD Hull","year":"1998","unstructured":"Hull RD, Pineo GF: Prophylaxis of deep venous thrombosis and pulmonary embolism: current recommendations. Cur Concepts of Thromb 1998, 82:477\u2013493.","journal-title":"Cur Concepts of Thromb"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1378\/chest.106.1.13","volume":"106","author":"MG Keane","year":"1994","unstructured":"Keane MG, Ingenito EP, Goldhaber SZ: Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest 1994, 106:13\u201314.","journal-title":"Chest"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM194811042391902","volume":"239","author":"JH Wisehart","year":"1948","unstructured":"Wisehart JH, Chapman CB: Dicumarol therapy in congestive heart failure. New Engl J Med 1948, 239:701\u2013704.","journal-title":"New Engl J Med"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00007611-194804000-00018","volume":"41","author":"GM Anderson","year":"1948","unstructured":"Anderson GM, Hull E: The use of dicumarol as an adjunct to the treatment of congestive heart failure. S Med J 1948, 41:365\u2013371.","journal-title":"S Med J"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1056\/NEJM195002092420603","volume":"242","author":"WP Harvey","year":"1950","unstructured":"Harvey WP, Finch CA: Dicumarol: Prophylaxis of thromboembolic disease in congestive heart failure. N Engl J Med 1950, 242:208\u2013211.","journal-title":"N Engl J Med"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM197303152881103","volume":"288","author":"AS Gallus","year":"1973","unstructured":"Gallus AS, Hirsh J, Tuttle RJ: Small subcutaneous dose of heparin in prevention of venous thrombosis. N Engl J Med 1973, 288:545\u2013551.","journal-title":"N Engl J Med"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(96)91009-0","volume":"347","author":"B Gardlund","year":"1996","unstructured":"Gardlund B: Randomized, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. Lancet 1996, 347:1357\u20131361.","journal-title":"Lancet"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-2007-996431","volume":"25","author":"S Haas","year":"1999","unstructured":"Haas S: Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients. Sem Thromb Hemost 1999, 25:101\u2013105.","journal-title":"Sem Thromb Hemost"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00003246-198207000-00006","volume":"10","author":"JF Cade","year":"1982","unstructured":"Cade JF: High risk of the critically ill for venous thromboembolism. Crit Care Med 1982, 10:448\u2013450.","journal-title":"Crit Care Med"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/01.CIR.94.9.2341","volume":"94","author":"TJ Ryan","year":"1996","unstructured":"Ryan TJ, Anderson JL, Antman, EM et al.: ACC\/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. Circulation 1996, 94:2341\u20132350.","journal-title":"Circulation"},{"key":"11_CR20","first-page":"159","volume":"16","author":"R Dahan","year":"1986","unstructured":"Dahan R, Houlbert D, Caulen C, et al.: Prevention of deep vein thrombosis in elderly medical in-patients by low molecular weight heparin: A randomized double-blind trial. Haemostasis 1986, 16:159\u2013164.","journal-title":"Haemostasis"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-96-5-561","volume":"96","author":"H Halkin","year":"1982","unstructured":"Halkin H, Goldberg J, Modan M, et al.: Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med 1982, 96:561\u2013565.","journal-title":"Ann Intern Med"},{"key":"11_CR22","first-page":"505","volume":"11","author":"C Ibarra-Perez","year":"1998","unstructured":"Ibarra-Perez C, Lau-Cortes E, Colmenero-Zuibate S, et al.: Prevalence and prevention of deep venous thrombosis of the lower extremities in high-risk pulmonary patients. Angiology 1998, 11:505\u2013513.","journal-title":"Angiology"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/003693308102600205","volume":"26","author":"JJ Belch","year":"1981","unstructured":"Belch JJ, Lowe DO, Ward AG, et al.: Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 1981, 26:115\u2013117.","journal-title":"Scott Med J"},{"key":"11_CR24","first-page":"889","volume":"82","author":"SZ Goldhaber","year":"1999","unstructured":"Goldhaber SZ: Venous thromboembolism prophylaxis in medical patients. Thromb Haemost 1999, 82:889\u2013901.","journal-title":"Thromb Haemost"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.1995.03530040063042","volume":"274","author":"DR Hirsh","year":"1995","unstructured":"Hirsh DR, Ingenito EP, Goldhaber SZ: Prevalence of deep venous thrombosis among patients in medical intensive care. J Am Med Assoc 1995, 274:335\u2013337.","journal-title":"J Am Med Assoc"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.7326\/0003-4819-128-9-199805010-00011","volume":"128","author":"FA Lederle","year":"1998","unstructured":"Lederle FA: Heparin prophylaxis for medical patients? Ann of Intern Med 1998, 128:768\u2013770.","journal-title":"Ann of Intern Med"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/archinte.1992.00400200092017","volume":"152","author":"FA Anderson","year":"1992","unstructured":"Anderson FA, Wheeler HB, Goldberg RJ, et al.: The prevalence of risk for venous thromboembolism smong hospital patients. Arch Intern Med 1992, 152:1660\u20131664.","journal-title":"Arch Intern Med"},{"key":"11_CR28","first-page":"127","volume":"26","author":"J Harenberg","year":"1996","unstructured":"Harenberg J, Roebruck P, Heene DL: Subcutaneous lowmolecular- weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. Haemostasis 1996, 26:127\u2013139.","journal-title":"Haemostasis"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0049-3848(90)90422-9","volume":"59","author":"J Harenberg","year":"1990","unstructured":"Harenberg J, Kallenbach B, Martin U, et al.: Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients. Thromb Res 1990, 59:639\u2013650.","journal-title":"Thromb Res"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0038-1650617","volume":"76","author":"JF Bergman","year":"1996","unstructured":"Bergman JF, Neuhart E: A multicenter randomized doubleblind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. Thromb Haemost 1996, 76:529\u2013534.","journal-title":"Thromb Haemost"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0735-1097(98)00006-0","volume":"31","author":"AS Al-Khadra","year":"1998","unstructured":"Al-Khadra AS, Salem DN, Rand WM et al.: Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol 1998, 31:749\u2013753.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-001-0011-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-001-0011-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-001-0011-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:37:06Z","timestamp":1587555426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-001-0011-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11886-001-0011-3","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}